Catalyst Pharmaceuticals (CPRX) Shares Outstanding (2017 - 2025)
Historic Shares Outstanding for Catalyst Pharmaceuticals (CPRX) over the last 9 years, with Q3 2025 value amounting to $123.3 million.
- Catalyst Pharmaceuticals' Shares Outstanding rose 335.21% to $123.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.3 million, marking a year-over-year increase of 335.21%. This contributed to the annual value of $120.9 million for FY2024, which is 1284.24% up from last year.
- As of Q3 2025, Catalyst Pharmaceuticals' Shares Outstanding stood at $123.3 million, which was up 335.21% from $122.4 million recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Shares Outstanding ranged from a high of $123.3 million in Q3 2025 and a low of $102.7 million during Q2 2022
- Over the past 5 years, Catalyst Pharmaceuticals' median Shares Outstanding value was $106.5 million (recorded in 2023), while the average stood at $110.5 million.
- As far as peak fluctuations go, Catalyst Pharmaceuticals' Shares Outstanding tumbled by 81.69% in 2022, and later soared by 1284.24% in 2024.
- Catalyst Pharmaceuticals' Shares Outstanding (Quarter) stood at $103.0 million in 2021, then grew by 2.2% to $105.3 million in 2022, then increased by 1.77% to $107.1 million in 2023, then increased by 12.84% to $120.9 million in 2024, then increased by 1.97% to $123.3 million in 2025.
- Its Shares Outstanding was $123.3 million in Q3 2025, compared to $122.4 million in Q2 2025 and $122.0 million in Q1 2025.